Serinus Biosciences develops technologies to understand how chemicals work inside malignant tumor cells.
Serinus Biosciences has raised $150K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2023.
Serinus Biosciences's investors include Y Combinator, Merck Digital Sciences Studio.
Serinus Biosciences is headquartered in New York, United States.
Serinus Biosciences develops technologies to understand how chemicals work inside malignant tumor cells.
Serinus Biosciences is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Serinus Biosciences — Funding & Investors." VCBacked, November 16, 2023, https://www.vcbacked.co/company/serinus-biosciences. Accessed November 15, 2026.
VCBacked. (2023). Serinus Biosciences — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/serinus-biosciences
{{cite web |title=Serinus Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/serinus-biosciences |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Serinus Biosciences? Request a listing update